Related Experiment Videos

Deletion of genes on chromosome 1 in endocrine neoplasia

Nature
|August 6, 1987
PubMed

Insights

Researchers investigated genetic deletions in Multiple Endocrine Neoplasia type 2 (MEN2) tumors. They found DNA deletions on chromosome 1 in half of the tumors analyzed, suggesting a role in MEN2 tumor development.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Tumorigenesis involves the loss of normal cellular DNA sequences.
  • Familial cancer syndromes often result from inherited mutations followed by loss of the normal gene copy.
  • Multiple Endocrine Neoplasia type 2 (MEN2) is an inherited cancer syndrome.

Purpose of the Study:

  • To locate the predisposing gene for Multiple Endocrine Neoplasia type 2 (MEN2).
  • To investigate constitutional and tumor genotypes in MEN2 patients with medullary thyroid carcinomas and phaeochromocytomas.

Main Methods:

  • Genotyping of constitutional DNA and tumor DNA from MEN2 patients.
  • Analysis of DNA deletions, specifically in a hypervariable region on chromosome 1 short arm.
  • Parental origin analysis of deleted alleles in familial cases.

Main Results:

  • Deletion of a hypervariable DNA region on chromosome 1 short arm was observed in 7 out of 14 MEN2 tumors.
  • Parental origin analysis indicated the deletion was not consistently linked to the inherited mutation site in MEN2.
  • The deleted region was found to be distal to the breakpoint common in neuroblastomas.

Conclusions:

  • The observed DNA deletions on chromosome 1 may be associated with MEN2 tumor development.
  • The deletions do not appear to directly represent the inherited mutation site in MEN2.
  • Further research is needed to pinpoint the exact predisposing gene in MEN2.

Related Concept Videos